Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Viridian Therapeutics Inc
1S1Current price
20.6 EUR
0 EUR (0.00%)
Last closed
21.64 USD
Company
www.viridiantherapeutics.com
ISIN
US92790C1045
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
1 924 947 200 USD
Yield for 12 month
+32.50 %
1Y
3Y
5Y
10Y
15Y
1S1
Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts. Address: 221 Crescent Street, Waltham, MA, United States, 02453
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
39.56 USDP/E ratio
–Dividend Yield
–Current Year
+314 000 USD
Last Year
+1 772 000 USD
Current Quarter
+72 000 USD
Last Quarter
+72 000 USD
Current Year
-1 008 000 USD
Last Year
+1 017 000 USD
Current Quarter
-5 719 000 USD
Last Quarter
-273 000 USD
Key Figures 1S1
1 year
3 years
5 years
10 years
EBITDA
-250 212 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-33.45 %
PEG Ratio
–
Return On Equity TTM
-53.97 %
Wall Street Target Price
39.56 USD
Revenue TTM
288 000 USD
Book Value
5.16 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-99 122 000 USD
Earnings per share
-4.25 USD
Diluted Eps TTM
-4.25 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 1S1
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 1S1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
13.11.2020
Dividend Date
13.11.2020
Stock Valuation 1S1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5466.1454
Price Sales TTM
6683.844
Enterprise Value EBITDA
-3.1816
Price Book MRQ
5.8398
Financials 1S1
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 1S1
For 52 weeks
11.4 USD
26.06 USD
50 Day MA
21.82 USD
Shares Short Prior Month
10 151 921
200 Day MA
17.09 USD
Short Ratio
7.85
Shares Short
9 791 768
Short Percent
14.64 %
BeatStart